Overview

Intravenous Lidocaine for Fibromyalgia

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
0
Participant gender:
All
Summary
The effect of intravenous lidocaine infusion on manifestations of fibromyalgia manifestations were recorded before and 4 weeks after treatment. Pain intensity was rated on a numerical scale.The combination of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or manifestations in patients with fibromyalgia.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- 18 to 60 years, with fibromyalgia (American College of Rheumatology criteria: pain in
the four quadrants of the body for at least 3 months and a minimum of 11 out of 18
tender points

Exclusion Criteria:

- Thyroid, rheumatological, renal and hepatic function

- Trauma

- Rheumatic, neuromuscular or psychiatric disease

- Infectious arthropathy

- Other pain syndromes

- Drug hypersensitivity; AND

- Pregnancy